Piramal Pharma Solutions Marks 20 Years with Korsch X3 Acquisition

Piramal Pharma Solutions celebrated the 20th anniversary of its Morpeth facility with the installation of a Korsch X3 high containment tablet press. This state-of-the-art equipment is custom-built for handling highly potent drug products safely at both clinical and commercial scales. The Korsch X3 enhances Morpeth's capacity to meet the growing demand for complex therapies, particularly those requiring Band 5 containment for high potency materials.

The acquisition of this advanced tablet press underlines Morpeth's commitment to innovation and safety in pharmaceutical manufacturing. Enhanced with the DryCon containment kit, the X3 offers greater operational efficiency, supporting 25mm tablet manufacturing and featuring a contained infeed system. The press's design ensures staff safety during production by minimizing exposure to toxic substances.

This strategic investment reflects Piramal's ongoing dedication to expanding its capabilities and reinforcing its position in the pharmaceutical industry. Morpeth's continued focus on advanced technology aims to improve therapeutic solutions for patients worldwide.